Evidence map›Paper›PMID 41758517›Full record

ArticleJAMA network open2026

Cognitive and Neuropsychiatric Function in Former American Football Players.

Anna Aaronson, Grace Badlam, Shania C Mulayi, Fatima Tuz-Zahra, Kelsey J Goostrey, Yorghos Tripodis, William S Cole-French, Matthew Roebuck, Greta Schneider, Brittany N Pine and 15 more

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Anna AaronsonBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
Grace BadlamBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
Shania C MulayiBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
Fatima Tuz-ZahraBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
Kelsey J GoostreyBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
Yorghos TripodisBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
William S Cole-FrenchBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
Matthew RoebuckBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
Greta SchneiderCenter for Health Data Science, Boston University School of Public Health, Boston, Massachusetts.
Brittany N PineCenter for Health Data Science, Boston University School of Public Health, Boston, Massachusetts.
Joseph N PalmisanoCenter for Health Data Science, Boston University School of Public Health, Boston, Massachusetts.
Brett M MartinCenter for Health Data Science, Boston University School of Public Health, Boston, Massachusetts.
Kenton H ZavitzCambridge Cognition, Cambridge, Massachusetts.
Douglas I KatzBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
Christopher J NowinskiBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
Ann C McKeeBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
Thor D SteinBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
R Scott MackinVA Advanced Research Center, San Francisco Veteran's Administration Medical Center, San Francisco, California.
Michael D McCleanBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
Jennifer WeuveDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts.
Jesse MezBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
Michael W WeinerVA Advanced Research Center, San Francisco Veteran's Administration Medical Center, San Francisco, California.
Rachel L NoshenyDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco.
Robert A SternBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
Michael L AloscoBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.

Funding

The Brain Health Registry for facilitating interdisciplinary aging researchR33AG062867 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NOSHENY, RACHEL LAUREN · 2020 to 2024
$3.2M
Blood Biomarker Development and Validation in Chronic Traumatic Encephalopathy and Alzheimer's Disease and Alzheimer's Disease Related DementiasR01NS132290 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Michael Alosco, Thor Stein · 2025 to 2026
$1.9M
NIA NIH HHS R33 AG062867NINDS NIH HHS R01 NS132290
6 · The paper itself

Abstract

Importance: Repetitive head impacts (RHI) from American football have been associated with later-life cognitive and neuropsychiatric changes. Findings have been limited by small samples, focus on elite players, and lack of appropriate control groups. Objective: To assess the association between American football participation and cognitive and neuropsychiatric function in men 40 years or older. Design, Setting, and Participants: In this cross-sectional study, online data from male football players in the Head Impact & Trauma Surveillance Study (HITSS) were collected between March 7, 2022, and April 9, 2025. In a subanalysis, football players were matched to Brain Health Registry controls without RHI. Exposures: RHI proxies, including self-reported total years of football play, highest level of play, position, and age of first exposure. Main Outcomes and Measures: Linear regression models with multiway cluster-robust SEs compared performance of players vs controls on computerized cognitive tests (Cambridge Automated Neuropsychological Battery Paired Associates Learning Test First Attempt Memory Score [PALFAMS] and Total Errors Adjusted [PALTEA]), subjective cognitive concerns (Everyday Cognition Scale [ECog]), and depressive symptoms (Geriatric Depression Scale 15 [GDS-15]). Multivariable linear regressions, analyses of covariance, and binary logistic regression models tested associations between RHI proxies and PALFAMS, PALTEA, ECog, GDS-15, and additional neuropsychiatric (Behavior Rating Inventory of Executive Function-Adult [BRIEF-A] Behavioral Regulation Index [BRI]) and cognitive (BRIEF-A Meta-Cognition Index [MI]) measures. Models were adjusted for age, race, educational level, and vascular risk. Results: The study sample included 3970 male former American football players (mean [SD] age, 55.93 [10.00] years) enrolled in HITSS. Two substudies were performed: (1) all 3970 football players and (2) 943 players and controls (mean [SD] age, 58.46 [10.37] years), including 661 football players and 282 Brain Health Registry controls. Overall, all study participants were highly educated (561 [85%] had a ≥4-year degree). Compared with controls, players had worse scores on PALFAMS (B = -0.64; 95% CI, -1.23 to 0.05; β = -0.15; P = .03), PALTEA (B = 0.31; 95% CI, 0.07-0.54; β = 0.18; P = .01), ECog (B = 0.11; 95% CI, 0.07-0.15; β = 0.38; P < .001), and GDS-15 (B = 0.62; 95% CI, 0.39-0.86; β = 0.37; P < .001). Among the 3970 total players (mean [SD] years of education, 16.11 [2.20]), professional players had worse scores than college and high school or youth players. Years of play was associated with higher ECog (B = 0.006; 95% CI, 0.003-0.009; adjusted P < .001), MI (B = 0.17; 95% CI, 0.02-0.32; adjusted P = .04), BRI (B = 0.27; 95% CI, 0.16-0.37; adjusted P < .001), GDS-15 (B = 0.03; 95% CI, 0.009-0.04; adjusted P = .003), and PALTEA (B = 0.03; 95% CI, 0.004-0.06; adjusted P = .04) scores. Conclusions and Relevance: In this cross-sectional study of former American football players, prior American football participation was associated with worse later-life cognitive and neuropsychiatric function. These findings support a dose-response association with years and level of play, providing context to help clinicians and researchers assess the risk of symptoms among former players.

Indexed as

Brain ConcussionCognitionFootballAdultAgedCross-Sectional StudiesHumansMaleMiddle AgedNeuropsychological TestsUnited States

Identifiers

PMID41758517
PMCPMC12949441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.